Home / Research / Manufacturers / Diamedix Corporation Medical-device intelligence
Diamedix Corporation: FDA clearances and recalls Research Diamedix Corporation in public FDA records: applicant and recalling-firm names, product codes, clearance history, and recall records.
Names and coverage This profile groups matching applicant and recalling-firm names found in covered FDA records. It does not imply a complete corporate family, current ownership, or every product marketed under a brand.
Names observed in the source
Capitalization and punctuation variants are normalized. Customer-entered watchlist aliases remain private.
Product codes in this company’s records Record activity in this scope 0 clearance records and 14 recall records in the covered releases, across 1 source company names and 10 product codes. Dated history runs from Sep 11, 2003 to Jan 5, 2018.
Monthly counts through October 2026 Month 510(k) decisions Recall initiations October 2025 0 0 November 2025 0 0 December 2025 0 0 January 2026 0 0 February 2026 0 0 March 2026 0 0 April 2026 0 0 May 2026 0 0 June 2026 0 0 July 2026 0 0 August 2026 0 0 September 2026 0 0 October 2026 0 0
Product codes represented Code and FDA device name Clearances Recalls GNP · Antiserum, Cf, Epstein-Barr Virus 0 2 LIP · Enzyme Linked Immunoabsorption Assay, Treponema Pallidum 0 2 LJY · Enzyme Linked Immunoabsorbent Assay, Mumps Virus 0 2 LLL · Extractable Antinuclear Antibody, Antigen And Control 0 2 LFZ · Enzyme Linked Immunoabsorbent Assay, Cytomegalovirus 0 1 LGC · Enzyme Linked Immunoabsorbent Assay, Herpes Simplex Virus, Non-Specific 0 1 LHL · Reagents, Antibody, Legionella, Direct & Indirect Fluorescent 0 1 LJB · Enzyme Linked Immunoabsorbent Assay, Rubeola Igg 0 1 LSE · Epstein-Barr Virus, Other 0 1 MST · Antibodies, Gliadin 0 1
All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.
Clearances and recall records 14 matching records Device / record Company in FDA record Source Source date Diamedix Is-Mumps IgG Enzyme Immunoassay Test Kit for In Vitro Diagnostic Use Catalog No. 720-540 Z-2573-2018 · LJYDiamedix Corporation Recall Jul 28, 2018FDA record creation date Diamedix Is-EBV-EA-D IgG Enzyme Immunoassay Test Kit for In Vitro Diagnostic Use Catalog No. 720-640 Z-2574-2018 · GNPDiamedix Corporation Recall Jul 28, 2018FDA record creation date Diamedix Is-CMV IgG Test Kit Z-1689-2016 · LFZDiamedix Corporation Recall May 17, 2016FDA record creation date Diamedix Is-Mumps IgG Test Kit
Diamedix Is-Mumps IgG Test Kit is an EIA procedure intended for the qualitative and semi-quantitative detection … Z-1685-2016 · LJYDiamedix Corporation Recall May 16, 2016FDA record creation date Diamedix Is-EBV-VCA IgG Test Kit
Diamedix Is-Mumps IgG Test Kit is an EIA procedure intended for the qualitative and semi-quantitative detectio… Z-1686-2016 · LSEDiamedix Corporation Recall May 16, 2016FDA record creation date Diamedix Is-EBV-EA-D IgG Test Kit
Diamedix Is-Mumps IgG Test Kit is an EIA procedure intended for the qualitative and semi-quantitative detecti… Z-1687-2016 · GNPDiamedix Corporation Recall May 16, 2016FDA record creation date The Is-anti-Sm test kits****Catalog No: 720-240***
Product Usage:
The Diamedix Is-anti-Sm Test Kit is an EIA procedure intended for the detection… Z-0445-2013 · LLLDiamedix Corporation Recall Jun 26, 2015FDA record creation date Product is labeled in part: "***is immunosimplicity***ENA-6 Screen***Enzyme Immunoassay Test Kit***Catalog No: 720-230***Exp. Date: 2012-05-31**… Z-1620-2012 · LLLDiamedix Corporation Recall May 21, 2012FDA classification date Product is labeled in part: "***is immunosimplicity***HSV 1&2 IgM***Enzyme Immunoassay Test Kit***For the Detection of HSV 1&2 IgM antibodies***… Z-1520-2012 · LGCDiamedix Corporation Recall May 10, 2012FDA classification date Measles IgG Enzyme Immunoassay Test Kit, DIAMEDIX. The assay is intended for the semi-quantitation of human IgG antibodies to measles virus in h… Z-0607-2009 · LJBDiamedix Corporation Recall Jan 7, 2009FDA classification date Is-anti-Gliadin IgG Enzyme Immunoassay Test Kit packaged in cardboard boxes with individual components secured within a foam insert. Catalog Numb… Z-1684-2008 · MSTDiamedix Corporation Recall Sep 16, 2008FDA classification date The Is-Legionella IgG/IgM/IgA test kits are packaged in cardboard boxes with individual components secured within a foam insert. Z-0541-05 · LHLDiamedix Corporation Recall Feb 15, 2005FDA classification date The Is-Syphilis TREP-CHEK (TM) Test Kit is a confirmatory in vitro enzyme immunoassay for the qualitative detection of Treponema pallidum IgG ant… Z-0325-05 · LIPDiamedix Corporation Recall Dec 17, 2004FDA classification date Product is packaged in a box and is labeled: Syphilis TREP-CHEK No. 720-100-10, 960 test, For in Vitro Diagnostic Use Lot 71303 Exp. Jun 04 Diame… Z-0513-04 · LIPDiamedix Corporation Recall Jul 20, 2004FDA classification date
Device classifications FDA dataset: Nov 9, 2026
Last successful check: Nov 22, 2026
Source classifications may change.
510(k) clearances FDA dataset: Nov 9, 2026
Last successful check: Nov 22, 2026
FDA publishes this dataset monthly.
Recall records FDA dataset: Nov 19, 2026
Last successful check: Nov 22, 2026
FDA publishes this dataset weekly.
Keep this research moving. Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.
Start a 14-day free trial ↗